This document presents a summary of results from the cross-cutting evaluation of seven operational research (OR) projects in the area of AIDS, tuberculosis and malaria funded by the 5% Initiative. Six of the projects evaluated were selected as part of…
By working closely with Country Coordinating Mechanisms, opening its board up to civil society organizations and encouraging dual track financing, the Global Fund has made multi-faceted governance one of its founding principles. Given the importance of this issue and of…
Since the early 2000s, around 20 community observatories focusing on access to health have emerged in different parts of Africa. In areas where dysfunctional health systems, in particular supply chain management issues, continue to persist (medical drugs and inputs stockout,…
Find out the Activity Report 2018 to know our main actions.
While drug users are among the most stigmatized and marginalized populations, the situation is even more challenging for young drug users and women, who are consequently underrepresented in harm reduction services as well as HIV prevention, screening, and treatment. Moreover,…
Health systems cannot be improved without also strengthening community systems. Indeed, community systems have a specific responsibility and capacities that are tailor-made for identifying, understanding and meeting the needs of marginalised and vulnerable people with little access to health care…
High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal’
Impact of sunlight exposure on the residual efficacy of biolarvicides Bacillus thuringiensis israelensis and Bacillus sphaericus against the main malaria vector, Anopheles gambiae
In 2017, the Ministry for Europe and Foreign Affairs commissioned a strategic review of the 5% Initiative, which led to bringing about changes in it and augmenting its budget for 2017-2019. Find out our main actions in the fight against…
The Global Fund Strategy (2017-2022): Investing to End Epidemics outlines our partnership’s bold agenda for 2017-2022 and is guided by the vision of a world free of the burden of AIDS, tuberculosis and malaria with better health for all. The…